Physiological Changes Induced Through MEP Conditioning in People With SCI
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Feb 24, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking for volunteers to help researchers understand how specific training can improve movement control in people with spinal cord injuries (SCI). After an SCI, the connections between the brain and muscles, which are essential for movement, can be disrupted. The study aims to strengthen these connections through a brain-spinal cord-muscle training program. Participants will engage in activities like standing, sitting, and walking while their muscle activity is monitored with small electrodes on their skin. Researchers will also use a technique called transcranial magnetic stimulation, which gently stimulates the brain without causing discomfort.
To be eligible for this study, participants should be at least one year post-injury and able to walk at least 10 meters, even with assistance. They should be medically stable and not have any serious health issues, cognitive impairments, or metal implants in their heads. The trial will involve around three sessions each week for four months, followed by fewer sessions for another three months, with each session lasting about an hour. This study could offer valuable insights into improving recovery and movement for those with SCI.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neurologically stable (\>1 year post SCI)
- • Medical clearance to participate
- • Ability to ambulate at least 10 m with or without an assistive device (except for parallel bars)
- • Signs of weak ankle dorsiflexion at least unilaterally
- • Expectation that current medication will be maintained without change for at least 3 months; stable use of anti-spasticity medication is accepted
- Exclusion Criteria:
- • motoneuron injury
- • known cardiac condition (e.g., history of myocardial infarction, congestive heart failure, pacemaker use)
- • medically unstable condition
- • cognitive impairment
- • history of epileptic seizures
- • metal implants in the cranium
- • implanted biomedical device in or above the ches (e.g., a cardiac pacemaker, cochlear implant)
- • no measurable MEP elicited
- • unable to produce any voluntary TA EMG activity
- • extensive use of functional electrical stimulation to the leg on a daily basis
- • pregnancy (due to changes in weight and posture and potential medical instability)
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Aiko K Thompson, PhD
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials